| Literature DB >> 35768640 |
Marco Solmi1,2,3,4,5, Minjin Song6, Dong Keon Yon7,8, Seung Won Lee9,10, Eric Fombonne11,12, Min Seo Kim13, Seoyeon Park6, Min Ho Lee6, Jimin Hwang14, Roberto Keller15, Ai Koyanagi16,17, Louis Jacob16,18, Elena Dragioti19,20, Lee Smith21, Christoph U Correll22,23,24,25, Paolo Fusar-Poli4,26,27,28, Giovanni Croatto29, Andre F Carvalho30, Jae Won Oh31, San Lee31,32, Corentin J Gosling5,33,34, Keun-Ah Cheon35, Dimitris Mavridis36,37, Che-Sheng Chu38,39,40, Chih-Sung Liang41,42, Joaquim Radua4,43,44, Laurent Boyer45, Guillaume Fond45, Jae Il Shin46, Samuele Cortese5,47,48,49,50.
Abstract
Autism spectrum disorder (ASD) substantially contributes to the burden of mental disorders. Improved awareness and changes in diagnostic criteria of ASD may have influenced the diagnostic rates of ASD. However, while data on trends in diagnostic rates in some individual countries have been published, updated estimates of diagnostic rate trends and ASD-related disability at the global level are lacking. Here, we used the Global Burden of Diseases, Injuries, and Risk Factors Study data to address this gap, focusing on changes in prevalence, incidence, and disability-adjusted life years (DALYs) of ASD across the world. From 1990 to 2019, overall age-standardized estimates remained stable globally. Both prevalence and DALYs increased in countries with high socio-demographic index (SDI). However, the age-standardized incidence decreased in some low SDI countries, indicating a need to improve awareness. The male/female ratio decreased between 1990 and 2019, possibly accounted for by increasing clinical attention to ASD in females. Our results suggest that ASD detection in low SDI countries is suboptimal, and that ASD prevention/treatment in countries with high SDI should be improved, considering the increasing prevalence of the disorder. Additionally, growing attention is being paid to ASD diagnosis in females, who might have been left behind by ASD epidemiologic and clinical research previously. ASD burden estimates are underestimated as GBD does not account for mortality in ASD.Entities:
Year: 2022 PMID: 35768640 DOI: 10.1038/s41380-022-01630-7
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992